Posts by Sunu S. Thomas, MD
-
Atrial Fibrillation and Heart Failure Prevention: Do We Need a Risk Score?
Atrial fibrillation (AF) and heart failure (HF) as individual cardiac conditions are associated with morbidity and mortality in epidemic proportions. With at least 3 million patients with AF and 5 million with HF in the United States, the clinical effect and the health economic burden cannot be underestimated.
Biography
Dr. Sunu Thomas joined the Cardiology Division at the Massachusetts General Hospital in July 2014 specializing in advanced heart failure, cardiac transplantation and mechanical circulatory support. After completing his medical education and Adult Cardiology training at the University of Toronto, he pursued his interest in advanced heart disease with fellowships at the Brigham and Women's Hospital and completed a specialized year of training dedicated to mechanical circulatory support therapies at Columbia Univeristy Medical Center. He broadened his expertise in hemodynamics and interventional heart failure therapies with a full interventional cardiology fellowship at Tufts Medical Center.
At the Massachusetts General Hospital, he is the Medical Director of the Cardiac ECMO program and Co-Director of the Resynchronization and Advanced Cardiac Therapeutics (ReACT) Program. His primary clinical and research interests focus on the use of mechanical circulatory support strategies as heart replacement therapies in patients with acute and chronic heart failure syndromes.